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Introduction
Embryo transfer (ET) has become more widespread in recent years as a way to improve 
cattle genetics. According to the annual statistical survey of the American Embryo 
Transfer Association, more than 200,000 fresh and frozen bovine embryos were 
transferred in 2008. But despite advancements in reproductive technologies that have 
occurred since ET was commercialized in the 1970s, industrywide pregnancy rates are 
only 62.4 and 56.9% for fresh and frozen-thawed ET, respectively. Using ET helps 
avoid problems from failed fertilization; however, fertilization failure has been charac-
terized as a relatively unimportant factor of pregnancy loss. Approximately 10% of preg-
nancy failures resulted from fertilization failure and another 10% from failed embryo 
development. Approximately 20 to 25% of the pregnancy loss in an ET program could 
be characterized as early embryonic loss.
Use of supplemental progesterone has been shown to reduce early embryonic loss and 
enhance growth of the early embryo. Post-artificial insemination (AI) supplementation 
with progesterone also increased pregnancy rates. In contrast to those studies, use of a 
controlled intravaginal drug release (CIDR) insert to supplement progesterone in ET 
recipients post-transfer was not effective in reducing early embryonic loss.
Use of human chorionic gonadotropin (hCG) to stimulate ovulation of ovarian follicles 
to form accessory corpora lutea (CL) has been reported to increase circulating proges-
terone concentrations and increase pregnancy rates when administered during the post-
breeding early luteal phase. More recent studies have determined that administration 
of 1,000 IU hCG was sufficient to ovulate a follicle. We recently administered 1,000 
IU hCG to beef cows 7 days post-AI and observed formation of accessory CL and an 
increase in progesterone concentrations 14 days post-AI. Further, hCG administration 
to ET recipients at the dosage of 1,500 IU on either day 5 or 6 post-estrus has produced 
results ranging from no improvement to greater pregnancy rates than controls.
The objectives of this study were to: (1) monitor recipients for formation and retention 
of accessory CL, (2) determine if the circulating progesterone concentrations of preg-
nant recipients that received hCG were greater than those in control recipients, and (3) 
determine if hCG would reduce early embryonic loss (i.e., between transfer and first 
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pregnancy diagnosis). We hypothesized that administration of hCG to recipients at 
ET would induce accessory CL, increase circulating progesterone concentrations, and 
reduce early embryonic loss.
Experimental Procedures
Mature beef cows at three locations (n = 719) received embryos approximately 7 days 
post-estrus if they had palpable CL. Fresh (n = 160) or frozen-thawed (n = 559) grade 1 
or 2 embryos and transfers were made according to standard techniques as described by 
the International Embryo Transfer Society (IETS Manual, third edition, Champaign, 
IL). Embryo transfers were performed by 2 experienced veterinarians (Cross Country 
Genetics North, Inc., Westmoreland, KS) at Locations 1 and 2. Transfers at Location 
3 were performed by a single experienced technician (Advanced Reproductive Associ-
ates, Daphne, AL). A single embryo was transferred to the uterine horn of the recipient 
ipsilateral to the CL. At the time of transfer, recipients alternately received either 1,000 
IU hCG (1 mL, Chorulon; Intervet, Inc., Millsboro, DE) or 1 mL saline. Recipients 
were assigned a body condition score (BCS; 1 = thin and 9 = very fat). Pregnancy diag-
noses were performed by transrectal ultrasonography (5.0 MHz linear-array transducer; 
Aloka 500 V; Corometrics Medical Systems, Inc., Wallingford, CT) at 35 and 65 days 
(mean) post-estrus.
Blood samples were collected from a coccygeal vessel at both pregnancy diagnoses in 
pregnant cows at Locations 1 and 2. Blood samples were refrigerated overnight and 
centrifuged the following morning. Blood serums were frozen at -4° F until the assay for 
progesterone was performed by radioimmunoassay.
Results and Discussion
Embryo transfer pregnancy rates did not differ among locations. Factors that signifi-
cantly affected ET pregnancy rates at the first pregnancy diagnosis of 719 recipients are 
shown in Table 1. Treatment with hCG (P=0.026) at ET and transfer of fresh embryos 
(P=0.016) increased the likelihood of pregnancy at the first diagnosis. Further, recipi-
ents having BCS >5 at the time of transfer tended (P=0.074) to have greater pregnancy 
rates than recipients having BCS ≤5.
Positive additive effects of hCG treatment, BCS, and embryo type are illustrated in 
Figure 1. Within BCS class (≤5 vs. >5), recipients receiving fresh embryos always had 
greater transfer pregnancy rates, and hCG treatment produced greater transfer preg-
nancy rates in all embryo type-BCS classes except for cows of greater BCS receiving 
frozen embryos.
Serum progesterone concentrations in pregnant cows were greater (P<0.05) in hCG-
treated recipients than recipients treated with saline at the time of the first (8.1 ± 
0.9 vs. 6.1 ± 0.8 ng/mL) and second pregnancy diagnosis (8.7 ± 0.9 vs. 6.5 ± 0.7 ng/
mL). Ovaries of pregnant recipients (n = 59) from Location 1 were monitored for the 
number of luteal structures at the time of both pregnancy diagnoses. All occurrences 
of accessory CL at the time of pregnancy diagnosis (20 of 29; 68.9%) on day 32 were 
detected in the hCG treatment. Nineteen multiple ovulating cows each had 1 accessory 
CL, and 1 cow formed 2 accessory CL. The proportion of recipients having 1 or more 
accessory CL was greater (P<0.001) after hCG treatment (68.9%) than after saline (0%).
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In summary, administration of hCG to ET recipients at the time of transfer increased 
the incidence of accessory CL, increased serum progesterone concentrations, and 
increased transfer pregnancy rates. Assuming equal viability of embryos transferred to 
cows receiving hCG or saline, the increased transfer pregnancy rates were interpreted 
to indicate that increased progesterone resulting from hCG-induced ovulation reduced 
early embryonic losses after transfer of embryos to recipients. As expected, pregnancies 
were more likely in recipients that received fresh embryos than in cows that received 
frozen-thawed embryos. The tendency for cows in better body condition (BCS >5) to 
have greater transfer pregnancy rates reiterates the importance of properly managing 
the nutrition program for the recipient herd. Monitoring BCS could help predict the 
success of an ET. The positive effects of hCG treatment helped improve transfer rates 
resulting from transfer of fresh embryos and improved BCS of recipients.
Implications
Administering 1,000 IU hCG (1 mL Chorulon) to ET recipients at the time of ET 
increased transfer pregnancy rates.
Table 1. Factors affecting embryo transfer pregnancy rates 
Item n Pregnancy rate, % AOR (95% CI)a P-value
Treatment
Saline 358 53.9 Referent
hCG 361 61.8 1.40 (1.04-1.89) 0.026
Embryo type
Frozen 559 55.5 Referent
Fresh 160 66.3 1.57 (1.08-2.27) 0.016
BCS
≤5 454 55.3 Referent
>5 265 62.3 1.33 (0.97-1.82) 0.074 
a AOR = adjusted odds ratio; CI = confidence interval. An example of how to interpret an odds ratio: Treatment 
with hCG was 1.4 times more likely to increase transfer pregnancy rates than saline (referent).
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Figure 1. Additive effects of hCG treatment at embryo transfer, body condition score 
(BCS), and type of embryo transferred on transfer pregnancy rates in beef cow recipients. 
Numbers in bar boxes represent the number of recipients treated with either saline or 
1,000 IU hCG at embryo transfer.
